Literature DB >> 9920093

Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro.

A Mayerhofer1, H C Hemmings, G L Snyder, P Greengard, S Boddien, U Berg, C Brucker.   

Abstract

The catecholamines norepinephrine and dopamine (DA) are present in the human ovary; in particular, in follicular fluid. Norepinephrine activates ovarian alpha- and beta-adrenergic receptors and modulates ovarian steroidogenesis, but the significance of ovarian DA is unclear. We examined whether a DA receptor of the D1-subtype (D1-R) is present in human ovary and in cultured human granulosa luteal cells (GC). Using RT-PCR, we cloned complementary DNAs from adult human ovarian and GC messenger RNAs, which are identical to the human D1-R sequence. In ovarian sections, D1-R protein was identified (by immunohistochemistry) in granulosa cells of large antral follicles, cells of the corpus luteum, as well as in cultured GC. An immunoreactive band of approximately Mr 50,000 was found in cultured luteinized GC using the same antiserum in Western blots. The D1-R in these cells was functional, because DA, alone or in the presence of the beta-receptor antagonist propranolol, caused cellular contraction. The selective D1-R agonist SKF-38393 induced a similar change in cytomorphology and increased the levels of media cAMP. SKF-38393 failed, however, to significantly affect basal and hCG-stimulated progesterone release in vitro, indicating that the activation of the D1-R was not directly linked to synthesis of progesterone, the major steroid of human GC. Estradiol synthesis likewise was not affected. Using RT-PCR and immunohistochemistry, we found that GC express DA- and cAMP-regulated phosphoprotein of Mr 32,000 (DARPP-32), a protein typically associated with neurons bearing the D1-R. In cultured GC, DA and SKF-38393 induced increased threonine-phosphorylation of DARPP-32, even in the presence of propranolol but not in the presence of D1-R antagonist SCH-23390. Taken together, the presence of DA and a functional DA receptor and DARPP-32 indicate that a novel, physiological regulatory pathway involving DA exists in the human ovary.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920093     DOI: 10.1210/jcem.84.1.5378

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Development of a novel protocol for isolation and purification of human granulosa cells.

Authors:  R A Chilvers; Y H Bodenburg; L A Denner; R J Urban
Journal:  J Assist Reprod Genet       Date:  2012-03-10       Impact factor: 3.412

Review 2.  Role of stress and sympathetic innervation in the development of polycystic ovary syndrome.

Authors:  Monika Greiner; Alfonso Paredes; Verónica Araya; Hernán E Lara
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

3.  Release of norepinephrine from human ovary: coupling to steroidogenic response.

Authors:  H E Lara; A Porcile; J Espinoza; C Romero; S M Luza; J Fuhrer; C Miranda; L Roblero
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

4.  Effects of ovarian dopaminergic receptors on ovulation.

Authors:  Berenice Venegas-Meneses; José Francisco Padilla; Claudia Elvira Juárez; José Luis Morán; Carolina Morán; Nora Hilda Rosas-Murrieta; Anabella Handal; Roberto Domínguez
Journal:  Endocrine       Date:  2015-05-30       Impact factor: 3.633

5.  Decorin is a part of the ovarian extracellular matrix in primates and may act as a signaling molecule.

Authors:  M Adam; S Saller; S Ströbl; J D Hennebold; G A Dissen; S R Ojeda; R L Stouffer; D Berg; U Berg; A Mayerhofer
Journal:  Hum Reprod       Date:  2012-08-11       Impact factor: 6.918

6.  Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans.

Authors:  Gregory A Dissen; Cecilia Garcia-Rudaz; Alfonso Paredes; Christine Mayer; Artur Mayerhofer; Sergio R Ojeda
Journal:  Endocrinology       Date:  2009-03-05       Impact factor: 4.736

7.  Dopamine D1 receptor activation rescues extinction impairments in low-estrogen female rats and induces cortical layer-specific activation changes in prefrontal-amygdala circuits.

Authors:  Colin D Rey; Jennifer Lipps; Rebecca M Shansky
Journal:  Neuropsychopharmacology       Date:  2013-12-17       Impact factor: 7.853

8.  DARPP-32, Jack of All Trades… Master of Which?

Authors:  Marion Yger; Jean-Antoine Girault
Journal:  Front Behav Neurosci       Date:  2011-09-08       Impact factor: 3.558

9.  Dopamine receptor repertoire of human granulosa cells.

Authors:  Veronica Rey-Ares; Nikolai Lazarov; Dieter Berg; Ulrike Berg; Lars Kunz; Artur Mayerhofer
Journal:  Reprod Biol Endocrinol       Date:  2007-10-25       Impact factor: 5.211

10.  Identification and characterization of Ca2+-activated K+ channels in granulosa cells of the human ovary.

Authors:  Matthias H Traut; Dieter Berg; Ulrike Berg; Artur Mayerhofer; Lars Kunz
Journal:  Reprod Biol Endocrinol       Date:  2009-04-08       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.